07 September 2018 - World Duchenne Awareness Day
Italfarmaco committed to its mission to contribute to the improvement of the quality and the prolongation of human lifespan, is proud to support the Duchenne Community and to recognize the World Duchenne Awareness Day.
Read more
25 July 2018 - World Drug Safety Congress Europe, 10-11 Settembre 2018, Amsterdam
Invited speaker: Margherita D’Antuono, QPPV Italfarmaco SpA
Read more
22 September 2017 - NATALBEN, line of pregnancy supplements of Italfarmaco, is the partner of Walking Day, the first Italian event dedicated to Walking
THE ART OF WALKING IN PREGNANCY IN THE WALKING DAY OF FLORENCE (October 1st) and MILAN (28/29 October)
Read more
21 September 2017 - ITF BECKER. A new therapeutic approach to the Becker Muscular Dystrophy (BMD)
Paolo Bettica, Vice President R&D ITALFARMACO S.p.A, interviewed for the ITF Becker project
Read more
27 June 2017 - A new therapeutic approach to the Becker muscular dypriophy, signed agreement
The signature meeting was held at the Regione Lombardia premises in the afternoon of June 27, 2017.
Read more
13 April 2017 - POR FESR 2014-2020: Linea innovazione (Innovation line)
The Italfarmaco's project "ITF-Becker a new therapeutic approach at the Becker Muscular Dystrophy (BMD)"
Read more
17 March 2017 - Peripheral occlusive arterial disease (PAD)
European objective of no amputations with early diagnosis and proper prevention; proper therapy could reduce amputations by 70%
Read more
02 March 2016 - Market launch of Akynzeo
Market launch of Akynzeo, new NK-1 antagonist serotonergic
Read more
30 September 2015 - Acquisition of Effik, S.A.
Italfarmaco Group announces the acquisition of the remaining 50% in Effik, S.A.
Read more
29 September 2015 - New Italfarmaco representative office in Vietnam
Opening of the new Group representative Office
Read more